Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Travis Perkins: Director/PDMR Shareholding
Travis Perkins: Director/PDMR Shareholding
Travis Perkins: Director/PDMR Shareholding
Travis Perkins: Total Voting Rights
Travis Perkins: Total Voting Rights
Travis Perkins: Total Voting Rights
Fuller, Smith & Turner PLC: Director/PDMR Shareholding
Fuller, Smith & Turner PLC: Director/PDMR Shareholding
Fuller, Smith & Turner PLC: Director/PDMR Shareholding
Fuller, Smith & Turner PLC: Block Listing-Interim Review
Fuller, Smith & Turner PLC: Block Listing-Interim Review
Fuller, Smith & Turner PLC: Block Listing-Interim Review
Fuller, Smith & Turner PLC: Total Voting Rights
Fuller, Smith & Turner PLC: Total Voting Rights
Fuller, Smith & Turner PLC: Total Voting Rights
Fullers Smith & Turner PLC: Treasury Stock
Fullers Smith & Turner PLC: Treasury Stock
Fullers Smith & Turner PLC: Treasury Stock
Travis Perkins: Directorate Change
Travis Perkins: Directorate Change
Travis Perkins: Directorate Change
Hardman & Co Research: Titon Holdings (TON): Condititoning
Hardman & Co Research: Titon Holdings (TON): Condititoning
Hardman & Co Research: Titon Holdings (TON): Condititoning
DGAP-News: ZEAL Network SE: Einladung zur Telefonkonferenz von ZEAL
DGAP-News: ZEAL Network SE: Einladung zur Telefonkonferenz von ZEAL
DGAP-News: ZEAL Network SE: Einladung zur Telefonkonferenz von ZEAL
DGAP-News: ZEAL Network SE: Invitation to the conference call of ZEAL
DGAP-News: ZEAL Network SE: Invitation to the conference call of ZEAL
DGAP-News: ZEAL Network SE: Invitation to the conference call of ZEAL
DGAP-News: ZEAL Network SE: 2019 was an exciting and successful year for ZEAL
DGAP-News: ZEAL Network SE: 2019 was an exciting and successful year for ZEAL
DGAP-News: ZEAL Network SE: 2019 was an exciting and successful year for ZEAL
DGAP-News: ZEAL Network SE: 2019 war ein spannendes und erfolgreiches Jahr für ZEAL
DGAP-News: ZEAL Network SE: 2019 war ein spannendes und erfolgreiches Jahr für ZEAL
DGAP-News: ZEAL Network SE: 2019 war ein spannendes und erfolgreiches Jahr für ZEAL
Travis Perkins: Director/PDMR Shareholding
Travis Perkins: Director/PDMR Shareholding
Travis Perkins: Director/PDMR Shareholding
Fuller, Smith & Turner PLC: Director/PDMR Shareholding
Fuller, Smith & Turner PLC: Director/PDMR Shareholding
Fuller, Smith & Turner PLC: Director/PDMR Shareholding
Fuller, Smith & Turner PLC: Director/PDMR Shareholding
Fuller, Smith & Turner PLC: Director/PDMR Shareholding
Fuller, Smith & Turner PLC: Director/PDMR Shareholding
Travis Perkins: Director / PDMR Shareholding
Travis Perkins: Director / PDMR Shareholding
Travis Perkins: Director / PDMR Shareholding
Travis Perkins: Total Voting Rights
Travis Perkins: Total Voting Rights
Travis Perkins: Total Voting Rights
Fullers Smith & Turner PLC: Treasury Stock
Fullers Smith & Turner PLC: Treasury Stock
Fullers Smith & Turner PLC: Treasury Stock
Fuller, Smith & Turner PLC: Total Voting Rights
Fuller, Smith & Turner PLC: Total Voting Rights
Fuller, Smith & Turner PLC: Total Voting Rights
Total Voting Rights
Total Voting Rights
Total Voting Rights
Fullers Smith & Turner PLC: Treasury Stock
Fullers Smith & Turner PLC: Treasury Stock
Fullers Smith & Turner PLC: Treasury Stock
Travis Perkins - Wickes Q4 2019 Trading update and Capital Markets Day: Continued strong performance across both Core and DIFM (Do-it-for-me)
Travis Perkins - Wickes Q4 2019 Trading update and Capital Markets Day: Continued strong performance across both Core and DIFM (Do-it-for-me)
Travis Perkins - Wickes Q4 2019 Trading update and Capital Markets Day: Continued strong performance across both Core and DIFM (Do-it-for-me)
Hardman & Co Research: Shield Therapeutics (STX): Good demand for Feraccru in Europe
Hardman & Co Research: Shield Therapeutics (STX): Good demand for Feraccru in Europe
Hardman & Co Research: Shield Therapeutics (STX): Good demand for Feraccru in Europe
Director/PDMR Shareholding
Director/PDMR Shareholding
Director/PDMR Shareholding
Director/PDMR Shareholding
Director/PDMR Shareholding
Director/PDMR Shareholding